GLP-1 Medications and Facial Volume Loss: What You Need to Know About “Ozempic Face” and How It Can Be Treated
- Vanessa Charest
- Jan 20
- 2 min read
GLP-1 receptor agonists such as Ozempic, Wegovy and Mounjaro have transformed the management of weight loss and metabolic health. However, rapid and significant weight reduction can also lead to noticeable changes in the face commonly referred to as “Ozempic face”.

Patients often report:
Facial hollowing
Loss of midface volume
Increased skin laxity
A more tired or aged appearance
Understanding the science behind these changes allows us to restore the face in a natural, medically led way.
Why GLP-1 Weight Loss Affects the Face
Facial ageing is not just about wrinkles. It is primarily driven by:
Loss of deep and superficial fat compartments
Reduction in structural support
Decline in collagen and elastin
Changes in skin thickness and quality
GLP-1 medications accelerate fat loss throughout the body, including the face. When weight loss is rapid, the skin and underlying support structures do not always have time to adapt, leading to deflation and laxity.
This is why some patients notice:
Flattening of the cheeks
Deepening of nasolabial folds
Temple hollowing
Early jowling
Why Traditional Filler Is Not Always the Best Solution
In cases of weight-loss-related facial ageing, simply replacing volume with hyaluronic acid filler can sometimes lead to:
Overfilled appearance
Heaviness
Loss of natural contour
The issue is not just volume loss — it is collagen depletion and structural weakening.
This is where biostimulatory injectables play a key role.
Biostimulators: Restoring Collagen, Structure and Support
Two of the most evidence-based treatments for post-weight-loss facial ageing are:
Sculptra (Poly-L-Lactic Acid)
Sculptra works by:
Stimulating your own fibroblasts
Increasing type I collagen production
Gradually restoring volume and skin thickness
It is ideal for:
Global facial volume loss
Skin thinning
Long-term collagen regeneration
Results develop gradually over several months and are long-lasting, making it particularly suitable for patients experiencing GLP-1-related facial deflation.
Radiesse (Calcium Hydroxylapatite)
Radiesse provides:
Immediate structural support
Long-term collagen stimulation
Improved skin firmness and contour
When used in diluted or hyper-diluted form, it also acts as a powerful biostimulator for:
Skin tightening
Texture improvement
Jawline and lower face support
A Medical, Individualised Approach
Not all “Ozempic face” is the same. Assessment should always include:
Facial anatomy
Degree of fat loss
Skin quality
Age-related structural changes
Ongoing weight loss plans
Treatment plans should focus on:
Gradual restoration
Collagen stimulation
Natural facial proportions
Long-term skin health
Final Thoughts
GLP-1 medications can be life-changing for health, but facial changes are a recognised side effect of rapid weight loss. The solution is not overfilling -
it is biological restoration.
With advanced treatments such as Sculptra and Radiesse, we can:
Rebuild collagen
Restore support
Improve skin quality
Achieve natural, refreshed results
Always seek assessment and treatment from a qualified medical professional experienced in facial anatomy and regenerative injectables.
Considering treatments like Sculptra or Radiesse for post-weight-loss facial changes? Book a consultation with Vanessa at Vanessa Charest Aesthetic to discuss a personalised, natural-looking approach.
.png)



Comments